New Drugs in the Ulcerative Colitis Pipeline: Prometheus Unbound

Affiliations

Editorial

Silvio Danese. Gastroenterology. 2020 Feb.

. 2020 Feb;158(3):467-470.

doi: 10.1053/j.gastro.2019.12.011. Epub 2019 Dec 17.

¹ IBD Center, Department of Gastroenterology, Humanitas University, Rozzano, Milan, Italy. Electronic address: sdanese@hotmail.com.

No abstract available

Comment on

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
Sandborn WJ, Ferrante M, Bhandari BR, Berliba E, Feagan BG, Hibi T, Tuttle JL, Klekotka P, Friedrich S, Durante M, Morgan-Cox M, Laskowski J, Schmitz J, D'Haens GR. Sandborn WJ, et al. Gastroenterology. 2020 Feb;158(3):537-549.e10. doi: 10.1053/j.gastro.2019.08.043. Epub 2019 Sep 4. Gastroenterology. 2020. PMID: 31493397 Clinical Trial.